Brief: Aceso Life Science Signed MOU With Scilex Holding
24/03/2021 11:50
March 24 (Reuters) - Aceso Life Science Group Ltd 0474.HK :
* SIGNED MEMORANDUM OF UNDERSTANDING WITH SCILEX HOLDING
* MOU FOR EXCLUSIVE LICENSE OF SCILEX SP-102
* EXPECTED TOTAL VALUE OF EXCLUSIVE LICENSE FOR GREATER
CHINA
TERRITORY WILL BE IN RANGE OF USD60 MILLION TO USD80 MILLION
* MOU ALSO FOR PRECLINICAL DATA TO SUPPORT LICENSE
APPLICATION FOR
SEMDEXA OR SP-102 IN MAINLAND CHINA FROM NMPA
Source text for Eikon: ID:nHKS5msTXK
Further company coverage: 0474.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aceso Life Science
See all newsBrief: Aceso Life Science Disposes 18.3 Million Future Data Shares From 4 To 8 June
Brief: Aceso Life Science To Subscribe For Imagi Fin Group Shares For HK$167.32 Million
Brief: Aceso Life Science Expected To Record Profit For HY
Brief: Aceso Life Science Says Repaid All Outstanding Indebtedness In Full
Brief: Aceso Life Science Says New Facility Loan Of GBP87.3 Million For 3 Years